Advertisement Hi-Tech Pharmacal acquires marketing rights of generic Lidocaine 5% Ointment - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Hi-Tech Pharmacal acquires marketing rights of generic Lidocaine 5% Ointment

Hi-Tech Pharmacal has entered into a licensing agreement with Septodont for marketing rights of generic Lidocaine 5% Ointment.

Hi-Tech is in the process of launching Lidocaine 5% Ointment, indicated for use as a local anesthetic, and the profits from the sale of the product will be shared with Septodont.

The product had sales of $25m for the 12 month period ended February 2012, according to IMS data.

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded prescription and OTC products.